| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |